Letter to Congressional Leadership re: Prescription Drug Pricing

Nearly 40 organizations representing America’s consumers, patients, workers, taxpayers and businesses call on Congress to finally end the pharmaceutical industry’s anticompetitive behaviors and unjustified, egregious pricing that makes drugs unaffordable to patients, employers and taxpayers.

Read the letter.

Files